Vanguard Investments Australia
BIIB icon

Vanguard Investments Australia’s Biogen BIIB Stock Holding History

Vanguard Investments Australia’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Buy
74,714
+1,446
+2% +$277K 0.04% 363
2026
Q1 		$13.4M Buy
+73,268
New +$13.5M 0.04% 387

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Investments Australia's BIIB Position: Q2 2026 in Review

Vanguard Investments Australia increased its Biogen (BIIB) stake by 2% in Q2 2026, buying an estimated $277K and bringing the position to 74,714 shares worth $16.1M. The position accounts for 0.04% of the portfolio, ranked #363.

Vanguard Investments Australia first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Vanguard Investments Australia held 74,714 shares of Biogen worth $16.1M as of Q2 2026.
  • Vanguard Investments Australia bought 1,446 Biogen shares in Q2 2026, an estimated $277K.
  • Biogen made up 0.04% of Vanguard Investments Australia's portfolio in Q2 2026, its #363 holding.
  • Vanguard Investments Australia first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.